Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Mercure Amsterdam City Hotel

Nov 08, 2023 8:30 AM - Nov 09, 2023 5:15 PM

Joan Muyskenweg 10, 1096 CJ Amsterdam, Netherlands

Global Forum for Qualified Persons for Pharmacovigilance (QPPV)

This Forum provides valuable insights into the most pressing issues QPPVs are facing today. This event has limited capacity, register early!


The DIA Global QPPV Forum is a must-attend conference for anyone involved in pharmacovigilance. With a focus on the most pressing issues facing the industry today, this year's topics include global QPPV challenges, trends requiring QPPV awareness, and the impact of modern technology on the field. In addition, we will continue our popular 'QPPV talks' - quick, inpirational sessions that provide practical insight into real-world cases.


With input from regulators and industry leaders from around the world, this conference promises to provide valuable insights into the most pressing issues facing QPPVs today - and don't forget our 'Hot Topics' session!


So join us at the DIA Global QPPV Forum to network with peers, gain valuable insights, and stay ahead of the curve in the ever-evolving role.


Why should you attend this conference?

I’m excited to meet you all face-to-face in Amsterdam. As always the program is packed with hot topic presentations and flourishing discussions that cover the entire equator of the QPPV planet. You will recognize many of your favorite sessions but will also get the chance to enter new fields of knowledge. Moreover, the agenda offers plenty of space to socialize and exchange thoughts and experiences with old and new colleagues. So make sure your passport is valid, locate your suitcase - and I’ll see you in November. The QPPV Forum is useful, interesting, and fun! – Magnus Ysander – EU & UK QPPV & Head Pharmacovigilance Excellence, AstraZeneca, Sweden

For me, the annual QPPV forum is the place to meet my colleagues in the field that have just joined or that have been in the QPPV role for decades, all sharing experiences and best-practices in that particular role that is at the core of the pharmacovigilance system. Every year, the agenda includes topics on the further globalization of the role, current developments in (guidance for) legislation and is a platform for interaction between regulators and industry. I am thrilled that this year is in a live setting again and am very much looking forward to meet you in person! – Angela Van der Salm – Director Pharmacovigilance, Managing Partner, DADA Consultancy, Netherlands


Free Session! Management of Shortages and the QPPV involvement

This session provides valuable insights and practical solutions shared by industry and regulators as well as clarify the expectations from the MHRA, including the role of the QPPV in this matter.


Want to learn more about Global Forum for Qualified Persons for Pharmacovigilance (QPPV)? You've come to the right site!

Continuing Education


Who should attend?

    • Global QPPVs/ Deputies
    • Regulators
    • Pharmacovigilance Consultants
    • Directors of Pharmacovigilance Oversight and Standards
    • Drug Safety Managers/Leaders
    • Auditors
    • Medical and Regulatory Affairs Experts
    • Aspiring PV Specialists/QPPVs

Short Course or Primer

To keep you at the forefront.

Nov 07, 2023

Pre-conference Workshop 1:

Introduction to the Role of QPPVs

Nov 07, 2023

Pre-conference Workshop 2:

Globalisation of PSMF

Program Committee

  • Gemma  Jimenez Sese
    Gemma Jimenez Sese Senior Director, Deputy EU QPPV
    AstraZeneca, Spain
  • Magnus  Ysander, MD
    Magnus Ysander, MD EU & UK QPPV & Head Pharmacovigilance Excellence
    AstraZeneca, Sweden
  • Angela  Van Der Salm, PhD, MSc
    Angela Van Der Salm, PhD, MSc Director PV, Managing partner
    DADA Consultancy B.V., Netherlands
  • Shahinaz  Badr
    Shahinaz Badr Pharmacovigilance Consultant and PVQA Auditor - EMEA
    Pharma Quality Europe, United Arab Emirates
  • Vicki  Edwards, RPh
    Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
    Abbvie, United Kingdom
  • Maarten  Lagendijk, MSc
    Maarten Lagendijk, MSc Deputy EU QPPV
    MSD, Netherlands
  • Elspeth  McIntosh, MBA, RN
    Elspeth McIntosh, MBA, RN Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Katarzyna  Swiderek, MPharm, RPh
    Katarzyna Swiderek, MPharm, RPh Director, Safety Evaluation Risk Management (SERM)
    GlaxoSmithKline, Poland
  • Kiernan  Trevett, MSc
    Kiernan Trevett, MSc Principal Quality Lead, PDQ Quality Assurance Process GVP
    Genentech, A Member of the Roche Group, United States
  • Claire  Longman, MSc
    Claire Longman, MSc Expert Pharmacovigilance Inspector
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Willemijn  van der Spuij, MSc
    Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.